Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

Pharma names lift FTSE, Barclays declines, USD jumps on hawkish Kaplan

Published 30/04/2021, 16:30
© Reuters

Key Points

  • FTSE 100 closing price of 6,970.60, +0.13%
  • AstraZeneca (NASDAQ:AZN) shares rise to top of the FTSE
  • Barclays falls despite increased profit
  • Darktrace soars on trading debut
  • USD jumps after Fed taper comments
  • Oil retreats as OPEC+ production due to come back online

By Samuel Indyk

Investing.com – The FTSE 100 finished marginally higher on Friday but still closed below the psychological 7,000 as some hawkish comments from Fed’s Kaplan appeared to dampen risk appetite. Kaplan, who is traditionally one of the more hawkish members on the FOMC, said it would be appropriate to start talking about asset purchases.

Riskier assets were also dampened by a study from Imperial College regarding the Pfizer (NYSE:PFE) vaccine. The study suggested that healthcare workers who have only had one dose of the jab were at risk from Covid variants.

“In those who have not previously been infected and have so far only received one dose of vaccine the immune response to variants of concern may be insufficient,” Imperial College said in the study.

The double whammy sent the US Dollar Index to fresh session highs and helped weigh on both EUR/USD and GBP/USD. GBP/USD dropped further away from the 1.4000 handle while EUR/USD dropped back towards 1.2000.

In individual stocks news, AstraZeneca (LON:AZN) shares led the FTSE 100 higher after recording an 11% increase in revenue in the first quarter. The company had $275mln from sales of its Covid-19 vaccine and is now aiming to deliver 200mln doses per month.

On the other end of the scale was Barclays (LON:BARC). The company still recorded a mammoth profit but failed to release funds for expected credit losses as some of its UK peers have done earlier this week. The bank reported a 35% decline in FICC income which also seemed to drag shares lower while also adding that costs this year were likely to be higher than 2020.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Shares in cyber security firm Darktrace jumped as much as 40% on their first day of trading after the initial listing price of 250 pence per share, which valued the company at £1.7bln.

WTI and Brent crude futures both fell on Friday amid the broad risk-off tone and stronger USD. As a reminder, next week Saudi Arabia and the rest of the OPEC+ group begin to roll back on production cuts announced at the start of the pandemic.

Latest comments

more absurd scaremongering from the Imperial loons
Nice news
what nice? don't forget put stop loss..
a an other speculation, very easy to predict outcome.
nice
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.